Prospective, randomized, open-label,clinical trial comparing the effects of azilsartan and amlodipine on blood pressure, endothelial function and makers for obesity/oxidative stress/chronic kidney diseases

Trial Profile

Prospective, randomized, open-label,clinical trial comparing the effects of azilsartan and amlodipine on blood pressure, endothelial function and makers for obesity/oxidative stress/chronic kidney diseases

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 01 Jul 2015

At a glance

  • Drugs Azilsartan (Primary) ; Amlodipine
  • Indications Essential hypertension
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 29 Jun 2015 Status changed from recruiting to active, no longer recruiting as reported by UMIN record.
    • 17 Sep 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top